Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic: the ChoCO-WSES Prospective Observational Multicenter International Study.

NCT04542512 is registered in ClinicalTrials.gov with Poissy-Saint Germain Hospital as lead sponsor.

NCT NCT04542512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04542512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Factors for Necrotic Cholecystitis During COVID-19 Pandemic: the ChoCO-WSES Prospective Observational Multicenter International Study.
Lead sponsor
Poissy-Saint Germain Hospital
Phase
Observational
Overall status
Unknown status
Start date
October 1, 2020
Completion date
December 31, 2021
Enrollment
800 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cholecystitis suppurative, cholecystitis, acute, cholecystitis; gangrenous, covid19